CUTAQUIG 165 mg/mL clinical trials

Influencing Progression of Airway Disease in Primary Antibody Deficiency

This study looks at people with primary antibody deficiency to see if a higher dose of immunoglobulin (Ig) replacement therapy can slow down lung problems. We'll compare lung changes over two years using scans and other health measures. This could help improve treatment for these conditions.